164 related articles for article (PubMed ID: 37383161)
1. Diagnostic Accuracy of Alpha-Methylacyl-CoA Racemase Immunohistochemical Expression for the Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas.
Nili F; Fathi S; Tavakoli M; Mirzaian E; Lotfi M
Iran J Pathol; 2023; 18(1):57-63. PubMed ID: 37383161
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of HNF1β, Napsin A and P504S/Alpha-Methylacyl-CoA Racemase (AMACR) as markers of endometrial clear cell carcinoma.
Travaglino A; Raffone A; Arciuolo D; Santoro A; Inzani F; Di Maio A; Visiello U; Fulgione C; Guida M; Mollo A; Insabato L; Zannoni GF
Pathol Res Pract; 2022 Sep; 237():154019. PubMed ID: 35907281
[TBL] [Abstract][Full Text] [Related]
3. Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas.
Nili F; Tavakoli M; Izadi Mood N; Saffar H; Sarmadi S
Iran J Pathol; 2020; 15(2):81-85. PubMed ID: 32215023
[TBL] [Abstract][Full Text] [Related]
4. Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.
Fadare O; Parkash V; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Rawish KR; Hecht JL; Desouki MM
Hum Pathol; 2013 Dec; 44(12):2814-21. PubMed ID: 24119561
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Fadare O; Zhao C; Khabele D; Parkash V; Quick CM; Gwin K; Desouki MM
Pathology; 2015 Feb; 47(2):105-11. PubMed ID: 25551297
[TBL] [Abstract][Full Text] [Related]
6. Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.
Ju B; Wang J; Yang B; Sun L; Guo Y; Hao Q; Wu J
Int J Gynecol Pathol; 2018 Jul; 37(4):388-396. PubMed ID: 28796747
[TBL] [Abstract][Full Text] [Related]
7. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
[TBL] [Abstract][Full Text] [Related]
8. Endometrioid Squamous Proliferations of the Endometrium Express Alpha-Methylacyl-CoA Racemase (P504s).
Tahir M; Samankan S; Huang M; Pinto A
Int J Gynecol Pathol; 2023 Nov; 42(6):576-581. PubMed ID: 37562065
[TBL] [Abstract][Full Text] [Related]
9. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
Huang W; Cheng X; Ji J; Zhang J; Li Q
Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
[TBL] [Abstract][Full Text] [Related]
10. Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
Fadare O; Desouki MM; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Parkash V; Hecht JL
Am J Surg Pathol; 2014 Feb; 38(2):189-96. PubMed ID: 24145649
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Wang J; Li Q; Cheng X; Xiong K; Qi Q; Huang W
Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):874-8. PubMed ID: 26888504
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma.
Fadare O; Liang SX
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):580-7. PubMed ID: 22495362
[TBL] [Abstract][Full Text] [Related]
13. Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype: Implications for Lynch Syndrome Screening.
Rodriguez M; Kang EY; Farrington K; Cook LS; Le ND; Karnezis AN; Lee CH; Nelson GS; Terzic T; Lee S; Köbel M
Am J Surg Pathol; 2021 Nov; 45(11):1452-1463. PubMed ID: 34534137
[TBL] [Abstract][Full Text] [Related]
14. Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract.
Pors J; Segura S; Cheng A; Ji JX; Tessier-Cloutier B; Cochrane D; Fix DJ; Park K; Gilks B; Hoang L
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):593-601. PubMed ID: 31361605
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of PD-L1 and its correlation with microsatellite status in endometrial and ovarian clear cell carcinomas: a cross-sectional study.
Ghasemi D; Ameli F; Nili F; Edjtemaei R; Sheikhhasani S
BMC Cancer; 2022 Dec; 22(1):1362. PubMed ID: 36581850
[TBL] [Abstract][Full Text] [Related]
16. Utility of AMACR immunohistochemical staining in differentiating Arias-Stella reaction from clear cell carcinoma of ovary and endometrium.
Nili F; Sadri M; Ameli F
BMC Cancer; 2023 Apr; 23(1):332. PubMed ID: 37041497
[TBL] [Abstract][Full Text] [Related]
17. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.
Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL
Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504
[TBL] [Abstract][Full Text] [Related]
18. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T
Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
[TBL] [Abstract][Full Text] [Related]
19. Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Miller EM; Tymon-Rosario J; Sunkara J; Harmon BE; Karabakhtsian RG; Novetsky AP
Int J Gynecol Cancer; 2018 Sep; 28(7):1318-1324. PubMed ID: 30036224
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study.
Kawaguchi R; Maehana T; Sugimoto S; Kawahara N; Iwai K; Yamada Y; Kimura F
Int J Gynecol Pathol; 2024 Jan; 43(1):25-32. PubMed ID: 37255450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
